Immunological detection of in vitro formed phosphatidylethanol - An alcohol biomarker - With monoclonal antibodies

Alcoholism: Clinical and Experimental Research

Volumn 32, Issue 6, 2008, Pages 921-928

  Nissinen, Antti E ^a   Mäkelä, Sanna M ^a   Vuoristo, Jussi T ^a   Liisanantti, Marja K ^a   Hannuksela, Minna L ^a   Hörkkö, Sohvi ^a   Savolainen, Markku J ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Alcohol Abuse; Antibody; Biomarker; Ethanol; Phosphatidylethanol

Indexed keywords

BIOLOGICAL MARKER; CARDIOLIPIN; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSSPHATIDYLETHANOL ANTIBODY; SERUM ALBUMIN;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CANCER CELL CULTURE; CASE REPORT; CELL STRAIN 2B1; CELL STRAIN 2E9; CHEMICAL STRUCTURE; CHROMATOGRAPHY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYBRIDOMA CELL CULTURE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IN VITRO STUDY; MALE; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; SPLEEN CELL; TANDEM MASS SPECTROMETRY;

ALCOHOLISM; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BASE SEQUENCE; BIOLOGICAL MARKERS; CELL LINE; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCEROPHOSPHOLIPIDS; HUMANS; HYBRIDOMAS; IMMUNIZATION; IMMUNOASSAY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA;

MUS;

EID: 44349121152     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2008.00656.x     Document Type: Article

References (45)

1. Aguilar L, Ortega-Pierres G, Campos B, Fonseca R, Ibanez M, Wong C, Farfan N, Naciff JM, Kaetzel MA, Dedman JR, Baeza I (1999) Phospholipid membranes form specific nonbilayer molecular arrangements that are antigenic. J Biol Chem 274 : 25193 25196.
2. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41 : 431 437.
3. Bertolaccini ML, Khamashta MA (2006) Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus 15 : 172 178.
4. Bicker W, Lammerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W (2006) Validated method for the determination of the ethanol consumption markers ethyl glucuronide, ethyl phosphate, and ethyl sulfate in human urine by reversed-phase/weak anion exchange liquid chromatography-tandem mass spectrometry. Anal Chem 78 : 5884 5892.
5. Binder CJ, Shaw PX, Chang MK, Boullier A, Hartvigsen K, Hörkkö S, Miller YI, Woelkers DA, Corr M, Witztum JL (2005) The role of natural antibodies in atherogenesis. J Lipid Res 46 : 1353 1363.
6. Campos B, Chames M, Lantry JM, Bill JP, Eis A, Brockman D, Neil J, Tischner E, Barton J, Wong C, Schwemberger S, Cornelius J, Myatt L, Baeza I, Hnat M (2006) Determination of non-bilayer phospholipid arrangements and their antibodies in placentae and sera of patients with hypertensive disorders of pregnancy. Placenta 27 : 215 224.
7. Doyle KM, Bird DA, al Salihi S, Hallaq Y, Cluette-Brown JE, Goss KA, Laposata M (1994) Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res 35 : 428 437.
8. Doyle KM, Cluette-Brown JE, Dube DM, Bernhardt TG, Morse CR, Laposata M (1996) Fatty acid ethyl esters in the blood as markers for ethanol intake. JAMA 276 : 1152 1156.
9. Frostegård J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Hörkkö S, Witztum JL (2005) Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 52 : 192 200.
10. Giudicelli V, Chaume D, Lefranc MP (2004) IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res 32 : W435 W440.
11. Gunnarsson T, Karlsson A, Hansson P, Johnson G, Alling C, Odham G (1998) Determination of phosphatidylethanol in blood from alcoholic males using high-performance liquid chromatography and evaporative light scattering or electrospray mass spectrometric detection. J Chromatogr B Biomed Sci Appl 705 : 243 249.
12. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45 : 953 961.
13. Hannuksela ML, Rantala M, Kesäniemi YA, Savolainen MJ (1996) Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. Arterioscler Thromb Vasc Biol 16 : 213 221.
14. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21 : 108 110.
15. Hansson P, Varga A, Gjerss S, Krantz P, Alling C (2000) Blood phosphatidylethanol as a marker of alcohol abuse: studies in primary health care and forensic medicine. Clin Chem 46 : A185.
16. Hansson P, Varga A, Krantz P, Alling C (2001) Phosphatidylethanol in post-mortem blood as a marker of previous heavy drinking. Int J Legal Med 115 : 158 161.
17. Hartmann S, Aradottir S, Graf M, Wiesbeck G, Lesch O, Ramskogler K, Wolfersdorf M, Alling C, Wurst FM (2007) Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 12 : 81 84.
18. Helander A, Beck O (2004) Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 50 : 936 937.
19. Hietala J, Koivisto H, Latvala J, Anttila P, Niemelä O (2006) IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers. Alcohol Clin Exp Res 30 : 1693 1698.
20. Hörkkö S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL (1996) Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 98 : 815 825.
21. Huusko TJ, Liisanantti MK, Nissinen AE, Kakko S, Savolainen ER, Vuoristo JT, Savolainen MJ (2007) Effects of phosphatidylethanol on mouse adipocyte differentiation and expression of stearoyl-CoA desaturase 1. Alcohol Clin Exp Res 31 : 376 382.
22. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 : 495 497.
23. Latvala J, Melkko J, Parkkila S, Järvi K, Makkonen K, Niemelä O (2001) Assays for acetaldehyde-derived adducts in blood proteins based on antibodies against acetaldehyde/lipoprotein condensates. Alcohol Clin Exp Res 25 : 1648 1653.
24. Liisanantti MK, Huhta K, Savolainen MJ (2004) Transfer of phosphatidylethanol between lipoproteins. Alcohol Clin Exp Res 28 : 1638 1642.
25. Liisanantti MK, Savolainen MJ (2005) Phosphatidylethanol in high density lipoproteins increases the vascular endothelial growth factor in smooth muscle cells. Atherosclerosis 180 : 263 269.
26. Mizuno M, Ryuke Y, Yoshida J (2002) Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models. Cancer Gene Ther 9 : 825 829.
27. Niemelä O (2007) Biomarkers in alcoholism. Clin Chim Acta 377 : 39 49.
28. Niemelä O, Sorvajärvi K, Blake JE, Israel Y (1995) Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis. Alcohol Clin Exp Res 19 : 1203 1208.
29. Schellenberg F, Schwan R, Mennetrey L, Loiseaux MN, Pages JC, Reynaud M (2005) Dose-effect relation between daily ethanol intake in the range 0-70 grams and %CDT value: validation of a cut-off value. Alcohol Alcohol 40 : 531 534.
30. Schmitt G, Aderjan R, Keller T, Wu M (1995) Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol 19 : 91 94.
31. Sillanaukee P, Olsson U (2001) Improved diagnostic classification of alcohol abusers by combining carbohydrate-deficient transferrin and gamma-glutamyltransferase. Clin Chem 47 : 681 685.
32. Steinbrecher UP, Fisher M, Witztum JL, Curtiss LK (1984) Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res 25 : 1109 1116.
33. Stibler H, Allgulander C, Borg S, Kjellin KG (1978) Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand 204 : 49 56.
34. Stibler H, Kjellin KG (1976) Isoelectric focusing and electrophoresis of the CSF proteins in tremor of different origins. J Neurol Sci 30 : 269 285.
35. Teschke R, Brand A, Strohmeyer G (1977) Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption. Biochem Biophys Res Commun 75 : 718 724.
36. Tuominen A, Miller YI, Hansen LF, Kesäniemi YA, Witztum JL, Hörkkö S (2006) A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler Thromb Vasc Biol 26 : 2096 2102.
37. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Gosselin ML, Dixon KL, Deeds JD, Acton SL, Tall AR, Huszar D (1998) Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 95 : 4619 4624.
38. Varga A, Hansson P, Johnson G, Alling C (2000) Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 50 (299 141 150.
39. Varga A, Hansson P, Lundqvist C, Alling C (1998) Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 22 : 1832 1837.
40. Wang Z, Raifu M, Howard M, Smith L, Hansen D, Goldsby R, Ratner D (2000) Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3′ to 5′ exonuclease activity. J Immunol Methods 233 : 167 177.
41. Wurst FM, Alling C, Aradottir S, Pragst F, Allen JP, Weinmann W, Marmillot P, Ghosh P, Lakshman R, Skipper GE, Neumann T, Spies C, Javors M, Johnson BA, Ait-Daoud N, Akhtar F, Roache JD, Litten R (2005a) Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res 29 : 465 473.
42. Wurst FM, Tabakoff B, Alling C, Aradottir S, Wiesbeck GA, Muller-Spahn F, Pragst F, Johnson B, Javors M, Ait-Daoud N, Skipper GE, Spies C, Nachbar Y, Lesch O, Ramskogler K, Hartmann S, Wolfersdorf M, Dresen S, Weinmann W, Hines L, Kaiser A, Lu RB, Ko HC, Huang SY, Wang TJ, Wu YS, Whitfield J, Snell LD, Wu C, Hoffman PL (2005b) World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence: back to the future. Alcohol Clin Exp Res 29 : 1268 1275.
43. Wurst FM, Vogel R, Jachau K, Varga A, Alling C, Alt A, Skipper GE (2003) Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res 27 : 471 476.
44. Yang SF, Freer S, Benson AA (1967) Transphosphatidylation by phospholipase D. J Biol Chem 242 : 477 484.
45. Yokoyama WM (2000) Production of monoclonal antibodies, in Current Protocols in Immunology (Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W eds chapter 2.6, pp. 1 9. John Wiley & Sons Inc., New York.